SCHEMBL16469809

SCHEMBL16469809

COC(=O)c1ccc(NS(=O)(=O)c2ccc(CO)cc2C)cc1F

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SIRT6 Q8N6T7 1/20 0.46
ALDH1A1 P00352 4/20 0.43
HSD17B10 Q99714 1/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
USP2 O75604 2/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
MAPT P10636 4/20 0.41
TP53 P04637 2/20 0.41
FABP4 P15090 3/20 0.41
POLB P06746 2/20 0.39
FABP5 Q01469 1/20 0.39
IDH1 O75874 1/20 0.39
THRB P10828 1/20 0.39
BRD4 O60885 1/20 0.39
CREBBP Q92793 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16528853 0.90 ALDH1A1 (0.54) SIRT6ALDH1A1HSD17B10MEN1KMT2A
SCHEMBL16469956 0.87 SIRT6 (0.43) SIRT6ALDH1A1HSD17B10MEN1KMT2A
SCHEMBL18009516 0.84 SIRT6 (0.52) SIRT6ALDH1A1HSD17B10MEN1KMT2A
SCHEMBL16470277 0.84 ALDH1A1 (0.49) ALDH1A1HSD17B10MEN1KMT2AHPGD
SCHEMBL16469334 0.83 ALDH1A1 (0.49) SIRT6ALDH1A1HSD17B10HPGDFABP4
SCHEMBL16469412 0.82 SIRT6 (0.46) SIRT6ALDH1A1HSD17B10MEN1KMT2A
SCHEMBL18027982 0.82 SIRT6 (0.46) SIRT6ALDH1A1HSD17B10MEN1KMT2A
SCHEMBL28624757 0.81 SIRT6 (0.46) SIRT6ALDH1A1HSD17B10MEN1KMT2A
SCHEMBL6971665 0.80 HTT (0.54) ALDH1A1MEN1KMT2AHPGDMAPT
SCHEMBL28127771 0.79 SIRT6 (0.44) SIRT6ALDH1A1HSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9533985-B2 Sulfonamide derivative and medicinal use thereof EA PHARMA CO., LTD. (JP) 2017-01-03 US disclosed
US-9533985-B2 Sulfonamide derivative and medicinal use thereof EA PHARMA CO., LTD. (JP) 2017-01-03 US disclosed
EP-2842945-B1 SULFONAMIDE DERIVATIVE AND MEDICINAL USE THEREOF EA PHARMA CO LTD (JP) 2016-10-26 EP disclosed
EP-2842945-B1 SULFONAMIDE DERIVATIVE AND MEDICINAL USE THEREOF EA PHARMA CO LTD (JP) 2016-10-26 EP disclosed
EP-2842945-A1 SULFONAMIDE DERIVATIVE AND MEDICINAL USE THEREOF AJINOMOTO CO., INC. (JP) 2015-03-04 EP disclosed
EP-2842945-A1 SULFONAMIDE DERIVATIVE AND MEDICINAL USE THEREOF AJINOMOTO CO., INC. (JP) 2015-03-04 EP disclosed
US-20150051395-A1 SULFONAMIDE DERIVATIVE AND MEDICINAL USE THEREOF AJINOMOTO CO., LTD. (JP) 2015-02-19 US disclosed
US-20150051395-A1 SULFONAMIDE DERIVATIVE AND MEDICINAL USE THEREOF AJINOMOTO CO., LTD. (JP) 2015-02-19 US disclosed
US-20150051395-A1 SULFONAMIDE DERIVATIVE AND MEDICINAL USE THEREOF AJINOMOTO CO., LTD. (JP) 2015-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150051395-A1 SULFONAMIDE DERIVATIVE AND MEDICINAL USE THEREOF ITGB4, ITGA4, ITGA2 SIRT6 2659/4885ALDH1A1 1151/4885HSD17B10 4530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.